AlphaYouLGND: Reardon Andrew discloses securities transactions
By AlphaYouPublished Form 4
Reardon Andrew
Reporting filer
Reardon Andrew reported Exercise or conversion in LIGAND PHARMACEUTICALS INC: 340 units of Common Stock, dated 2026-10-02. The full Form 4 contains 8 transaction entries.
- Disclosed
- Oct 6, 2026
Reported details
8 entries| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Reardon Andrew | 2026-10-02 | M | Exercise or conversion | 340 | 52.27 | 36,854 | 4 days | Filed terms
|
| Common Stock | Reardon Andrew | 2026-10-02 | S | Sale | 833 | 302.5107 | 36,021 | 4 days | Filed terms
|
| Common Stock | Reardon Andrew | 2026-10-02 | S | Sale | 1976 | 303.5444 | 34,045 | 4 days | Filed terms
|
| Common Stock | Reardon Andrew | 2026-10-02 | S | Sale | 1535 | 304.5154 | 32,510 | 4 days | Filed terms
|
| Common Stock | Reardon Andrew | 2026-10-02 | S | Sale | 404 | 306.1834 | 32,106 | 4 days | Filed terms
|
| Common Stock | Reardon Andrew | 2026-10-02 | S | Sale | 235 | 307.1911 | 31,871 | 4 days | Filed terms
|
| Common Stock | Reardon Andrew | 2026-10-02 | S | Sale | 17 | 307.74 | 31,854 | 4 days | Filed terms
|
| Employee Stock Option (right to buy) (derivative) | Reardon Andrew | 2026-10-02 | M | Exercise or conversion | 340 | 0 | 29,104 | 4 days | Filed terms
|
Common Stock
- Owner
- Reardon Andrew
- Date
- 2026-10-02
- Code
- M
- Action
- Exercise or conversion
- Quantity
- 340
- Price
- 52.27
- Following holdings
- 36,854
- Reporting delay
- 4 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-10-02
- transaction Form Type: 4
- transaction Code: M
- equity Swap Involved: 0
- transaction Shares: 340
- id: F1
- transaction Price Per Share: 52.27
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 36854
- direct Or Indirect Ownership: D
Common Stock
- Owner
- Reardon Andrew
- Date
- 2026-10-02
- Code
- S
- Action
- Sale
- Quantity
- 833
- Price
- 302.5107
- Following holdings
- 36,021
- Reporting delay
- 4 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-10-02
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: 0
- transaction Shares: 833
- id: F1
- transaction Price Per Share: 302.5107
- id: F2
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 36021
- direct Or Indirect Ownership: D
Common Stock
- Owner
- Reardon Andrew
- Date
- 2026-10-02
- Code
- S
- Action
- Sale
- Quantity
- 1976
- Price
- 303.5444
- Following holdings
- 34,045
- Reporting delay
- 4 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-10-02
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: 0
- transaction Shares: 1976
- id: F1
- transaction Price Per Share: 303.5444
- id: F3
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 34045
- direct Or Indirect Ownership: D
Common Stock
- Owner
- Reardon Andrew
- Date
- 2026-10-02
- Code
- S
- Action
- Sale
- Quantity
- 1535
- Price
- 304.5154
- Following holdings
- 32,510
- Reporting delay
- 4 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-10-02
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: 0
- transaction Shares: 1535
- id: F1
- transaction Price Per Share: 304.5154
- id: F4
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 32510
- direct Or Indirect Ownership: D
Common Stock
- Owner
- Reardon Andrew
- Date
- 2026-10-02
- Code
- S
- Action
- Sale
- Quantity
- 404
- Price
- 306.1834
- Following holdings
- 32,106
- Reporting delay
- 4 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-10-02
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: 0
- transaction Shares: 404
- id: F1
- transaction Price Per Share: 306.1834
- id: F5
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 32106
- direct Or Indirect Ownership: D
Common Stock
- Owner
- Reardon Andrew
- Date
- 2026-10-02
- Code
- S
- Action
- Sale
- Quantity
- 235
- Price
- 307.1911
- Following holdings
- 31,871
- Reporting delay
- 4 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-10-02
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: 0
- transaction Shares: 235
- id: F1
- transaction Price Per Share: 307.1911
- id: F6
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 31871
- direct Or Indirect Ownership: D
Common Stock
- Owner
- Reardon Andrew
- Date
- 2026-10-02
- Code
- S
- Action
- Sale
- Quantity
- 17
- Price
- 307.74
- Following holdings
- 31,854
- Reporting delay
- 4 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-10-02
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: 0
- transaction Shares: 17
- id: F1
- transaction Price Per Share: 307.74
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 31854
- direct Or Indirect Ownership: D
Employee Stock Option (right to buy) (derivative)
- Owner
- Reardon Andrew
- Date
- 2026-10-02
- Code
- M
- Action
- Exercise or conversion
- Quantity
- 340
- Price
- 0
- Following holdings
- 29,104
- Reporting delay
- 4 days
- Filed terms and references
Filed terms
- security Title: Employee Stock Option (right to buy)
- conversion Or Exercise Price: 52.27
- transaction Date: 2026-10-02
- transaction Form Type: 4
- transaction Code: M
- equity Swap Involved: 0
- transaction Shares: 340
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: D
- id: F7
- expiration Date: 2032-08-01
- underlying Security Title: Common Stock
- underlying Security Shares: 340
- shares Owned Following Transaction: 29104
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Reardon Andrew: CLO & Secretary.
- The filing reports a Rule 10b5-1 trading plan.
- F1: The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on June 4, 2026, in accordance with Rule 10b5-1.
- F2: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $302.14 to $303.06. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F3: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $303.14 to $304.12. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F4: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $304.19 to $305.01. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F5: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $305.71 to $306.46. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F6: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $306.72 to $307.54. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F7: The stock option vests and is exercisable as to 12.5% of the underlying shares on February 1, 2023, and in 42 substantially equal monthly installments thereafter.
Original sources
Prepared automatically from public filing data. Report a correction.